(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
TRADING UPDATES: Longboat comes up empty; Intercede wins US contract Read More
Allergy Therapeutics gets US FDA approval for peanut vaccine trial Read More
TRADING UPDATES: Mobile Streams wins deal; East Imperial revenue jumps Read More
UK shareholder meetings calendar - next 7 days Read More
EXECUTIVE CHANGES: GSK adds scientific heft to board ahead of demerger Read More
Allergy Therapeutics shares jump on positive G309 trial results Read More
EARNINGS UPDATES: Harbour Energy enters black; Fonix profit rises Read More
IN BRIEF: Allergy Therapeutics cheers secondary endpoint results Read More
IN BRIEF: Allergy Therapeutics study confirms peanut vaccine potential Read More
Allergy Therapeutics expects revenue rise in year despite challenges Read More
TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook Read More
TRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge Read More
TRADING UPDATES: Capita sells Irish unit; Daily Mail buys science mag Read More
IN BRIEF: Allergy Therapeutics Hails Growth; Non-Exec Smith To Leave Read More
IN BRIEF: Allergy Therapeutics And Imperial Start Peanut Allergy Study Read More
IN BRIEF: Allergy Therapeutics Shareholders Revolt At General Meeting Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth Read More
IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study Read More
